E
Xilio Therapeutics, Inc. XLO
$0.7204 $0.01141.61%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings XLO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Weak
Risk Grade D-
Reward Grade E
Rating Factors XLO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Fair
Efficiency Index Very Weak
Solvency Index Good
Total Return Index Very Weak
Volatility Index Weak
Beta / Standard Deviation XLO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 1.45
Price History XLO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 30.98%
30-Day Total Return 6.11%
60-Day Total Return -19.96%
90-Day Total Return -61.75%
Year to Date Total Return 25.29%
1-Year Total Return -75.62%
2-Year Total Return -92.44%
3-Year Total Return --
5-Year Total Return --
52-Week High % Change -80.37%
52-Week Low % Change 47.02%
Price XLO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $3.67
52-Week Low Price $0.49
52-Week Low Price (Date) Dec 20, 2023
52-Week High Price (Date) Apr 12, 2023
Valuation XLO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap $19.83M
Enterprise Value -25.49M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -2.96
Earnings Per Share Growth -12.57%
Price/Earnings To Growth --
Price/Sales (TTM) --
Price/Book (Q) 0.38
Enterprise Value/Revenue (TTM) --
Price $0.72
Enterprise Value/EBITDA (TTM) 0.31
Enterprise Value/EBIT 0.30
Market Cap Category Nano Cap
Dividends and Shares XLO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 27.524M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info XLO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 857 524 2466
Address 828 Winter Street Waltham, MA 02451
Website xiliotx.com
Country United States
Year Founded 2016
Profitability XLO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) --
Profit Margin --
Management Effectiveness XLO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -44.72%
Return on Equity --
Income Statement XLO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) --
Total Revenue (TTM) --
Revenue Per Share --
Gross Profit (TTM) --
EBITDA (TTM) -$82.23M
EBIT (TTM) -$84.17M
Net Income (TTM) -$81.22M
Net Income Avl. to Common (TTM) -$81.22M
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) 15.37%
EPS Diluted (TTM) -$2.96
EPS Diluted Growth (Q YOY) 15.76%
Balance Sheet XLO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) $59.77M
Cash Per Share (Q) $2.17
Total Current Assets (Q) $64.48M
Total Preferred Equity (Q) --
Total Equity (Q) $52.50M
Current Ratio (Q) 3.809
Book Value Per Share (Q) $1.91
Total Assets (Q) $77.84M
Total Current Liabilities (Q) $16.93M
Total Debt (Q) $14.45M
Total Liabilities (Q) $25.34M
Total Common Equity (Q) $52.50M
Cash Flow XLO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) -$995.00K
Cash from Financing (TTM) -$4.94M
Net Change in Cash (TTM) -$79.35M
Levered Free Cash Flow (TTM) -$46.23M
Cash from Operations (TTM) -$73.42M
Weiss Ratings